These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4212405)

  • 1. The effect of hydergine on the transit time of cerebral circulation in diffuse cerebral insufficiency.
    Mongeau B
    Eur J Clin Pharmacol; 1974; 7(3):169-75. PubMed ID: 4212405
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydergine effect on cerebral circulation in cerebrovascular disease.
    McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
    J Neurol Sci; 1971 Aug; 13(4):475-81. PubMed ID: 4998934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of drugs on cerebrovascular circulation with special regard to Hydergin].
    Radielović P
    Lijec Vjesn; 1971; 93(11):1227-32. PubMed ID: 5005614
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydergine for cerebral arteriosclerosis.
    Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of hydergine in acute ischemic pathology of the brain].
    Gomensoro JB
    Acta Neurol Latinoam; 1967; 13(1):273-82. PubMed ID: 4976823
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ergot alkaloids (Hydergine) on cerebral haemodynamics in man.
    Olesen J; Skinhej E
    Acta Pharmacol Toxicol (Copenh); 1972; 31(1):75-85. PubMed ID: 4623450
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 16. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacodynamics of the cerebral circulation. Angiographic study].
    Cappellini M; De Marzi S
    Nunt Radiol; 1967 Nov; 33(11):1343-62. PubMed ID: 4977950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 19. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ergot alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys.
    Szewczykowski J; Meyer JS; Kondo A; Nomura F; Teraura T
    J Neurol Sci; 1970 Jan; 10(1):25-31. PubMed ID: 4983718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.